Pharma Focus America
ThermoFisherScientific - Custom and Bulks

LATEST NEWSRead more...

18

Jun 2024

Gyros Protein Technologies Launches Gyrolab Generic Anti-AAV Kit to Propel Gene Therapy Innovation

Gyros Protein Technologies AB known for its pioneering work in automated nanoliterscale immunoassays and peptide synthesizers has introduced the Gyrolab Generic AntiAdeno Associated Virus

17

Jun 2024

Adalvo Receives Initial EU Approval for Generic Liraglutide Prefilled Pen

Adalvo has announced the successful approval of the liraglutide prefilled pen under the EUs DCP marking a milestone as the first generic drug approval in the region According to IQVIA reports this peptide drug a bioequivalent of the Victoza prefilled pen and used for treating type diabetes achieved...

14

Jun 2024

Jumpcode Genomics and Takara Bio USA Establish Worldwide Patent Collaboration

Jumpcode Genomics a company specializing in genomic technologies and Takara Bio USA Inc a subsidiary of Takara Bio Inc have ended their patent dispute and agreed to collaborate This partnership focuses

14

Jun 2024

Santa Ana Bio Launches with $168 Million for Advancing Precision Medicines in Inflammatory Diseases

Santa Ana Bio a company specializing in precision immunology has publicly launched with million in funding from Series A and B rounds The Series A funding round was led by Versant Ventures

13

Jun 2024

KSQ Therapeutics Launches Clinical Trial for KSQ-001EX, a CRISPR/Cas9 Modified Tumor Infiltrating Lymphocyte Therapy

KSQ Therapeutics Inc a clinicalstage biotechnology firm dedicated to developing treatments for solid tumors has commenced the first patient in its Phase clinical trial for KSQEX an innovative

13

Jun 2024

Allay Therapeutics Gets FDA Approval for IND Application to Launch Phase 2B Study of ATX101 for Treating Pain After Knee Surgery

Allay Therapeutics a clinicalstage biotechnology company has announced its intention to advance to a Phase b registration trial for its leading investigational product ATX This trial will be based on solid data

press releasesRead more...

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051

Aprea Therapeutics Inc a clinicalstage biopharmaceutical company focused on precision oncology through synthetic lethality today announced that the first patient has been dosed in the ACESOT Phase study evaluating

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

Merck known as MSD outside of the United States and Canada announced today that the US Food and Drug Administration has approved CAPVAXIVE

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

Grifols one of the worlds leading producers of plasmaderived medicines today announced that Biotest a Grifols Group company has received approval from the United States Food and Drug Administration

Zymeworks Announces FDA Clearance Of Investigational New Drug Application For ZW171, A Novel 2+1 T-Cell Targeting Bispecific Antibody For Mesothelin-Expressing Cancers

Zymeworks Inc a clinicalstage biotechnology company developing a diverse pipeline of novel multifunctional biotherapeutics to improve the standard of care

18 - 19

Jun 2024

18 - 20

Jun 2024

18 - 19

Jun 2024

18 - 20

Jun 2024

18 - 19

Jun 2024

5th RNA Editing Summit

Boston, MA, USA

19 - 21

Jun 2024

CPHI & PMEC China 2024

Shanghai, China

20 - 22

Jun 2024

VACCINESFORUM2024

Porto, Portugal

Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific viral vector services (VVS)
Future Labs Live USA 2024
patheon - Mastering API production at every scale
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    Challenges and Opportunities in Market Access for New Drugs

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    The Critical Role of Contract Research Organizations in Pharma Development

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    Understanding Over-the-Counter (OTC) Drugs: Trends and Opportunities in Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Navigating the Storm: Emerging Challenges in the Pharmaceutical Industry

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Pharmacovigilance in the Age of AI: Enhancing Drug Safety with Technology

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues